Skip to main content
Premium Trial:

Request an Annual Quote

Fluxion Bio Lands NIH Grant for Antimicrobial Microfluidic Systems

NEW YORK (GenomeWeb News) – Microfluidic systems developer Fluxion Biosciences has received a Phase I grant from the National Institutes of Health to develop a platform for use in antimicrobial drug discovery and development programs, the company said today.
 
The San Francisco-based company did not disclose the amount of the grant and was not immediately available for comment.
 
The goal of the company’s research under the grant is to develop a higher throughput microfluidic system that will enable detection methods to enhance antimicrobial effectiveness and systems for conducting multi-point dose response curves, Fluxion said.
 
"The ability to rapidly screen and characterize antimicrobial compounds will be a powerful tool for developing the next generation of drug therapies," Carolyn Conant, grant project leader, said in a statement.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.